Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

IMS 2023 | Inequality in access to CAR-T therapy in multiple myeloma and the importance of addressing this

Larry Anderson, MD, PhD, UT Southwestern Medical Center, Dallas, TX, briefly discusses the problem of inequality in access to CAR-T therapy in multiple myeloma, which has been suboptimal due to limited slot availability, and further comments on the need to improve access if these agents are moved into earlier lines of therapy. This interview took place at the 20th International Myeloma Society (IMS) Annual Meeting, held in Athens, Greece.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.


Advisory/consultant to BMS, Janssen, Celgene, AbbVie, GSK